読み込み中
NASDAQHealthcareMedical - Distribution
最新データ
$0.112
+$0.0112 · +11.11%
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
前日終値
$0.112
+$0.0112 · +11.11%
日中の時刻はETです。市場データは遅延する場合があります。
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
日中レンジ
現在 $0.112
52週レンジ
現在 $0.112
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
65
割安
センチメント
51
まちまち
リスク
85
極めて高いリスク
モメンタム
19
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
日中レンジ
現在 $0.112
52週レンジ
現在 $0.112
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2026年度 | 2025年度 | 2024年度 | 2023年度 |
|---|---|---|---|---|
| 売上高 | 1343.35万 USD | 2031.38万 USD | 1668.84万 USD | 1255.6万 USD |
| 売上原価 | 1204.72万 USD | 1789.87万 USD | 1312.97万 USD | 981.71万 USD |
| 粗利益 | 138.63万 USD | 241.52万 USD | 355.87万 USD | 273.89万 USD |
| 販売・一般管理 | 239.51万 USD | 221.59万 USD | 188.95万 USD | 175.81万 USD |
| 営業費用 | 238.12万 USD | 228.31万 USD | 195.04万 USD | 169.51万 USD |
| 受取利息 | — | 1741 USD | 474 USD | 219 USD |
| 支払利息 | 13.34万 USD | 9.77万 USD | 8.28万 USD | 2.32万 USD |
| 減価償却費と償却費 | 68.71万 USD | 107.34万 USD | 92.56万 USD | 71.46万 USD |
| 営業利益 | −99.49万 USD | 13.2万 USD | 160.83万 USD | 104.38万 USD |
| 純利益 | −113.6万 USD | −2.71万 USD | 132.97万 USD | 99.82万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
